La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole

Identifieur interne : 003265 ( Main/Exploration ); précédent : 003264; suivant : 003266

Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole

Auteurs : Christopher J. D. Sinclair [Canada] ; Ljiljana Krizanac-Bengez [États-Unis] ; Kathë A. Stanness [États-Unis] ; Damir Janigro [États-Unis] ; Fiona E. Parkinson [Canada]

Source :

RBID : ISTEX:AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611

English descriptors

Abstract

Adenosine is an inhibitory neuromodulator in the central nervous system and has been reported to have neuroprotective properties. Using a dynamic in vitro blood–brain barrier, we investigated the hypothesis that inhibition of adenosine transporters on the lumenal side of the blood–brain barrier may decrease the loss of adenosine from the brain. Our results indicate that lumenal administration of dipyridamole, a nucleoside transport inhibitor, can inhibit adenosine permeation from the extracapillary space into the lumen.

Url:
DOI: 10.1016/S0006-8993(01)02175-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole</title>
<author>
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
</author>
<author>
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</author>
<author>
<name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
</author>
<author>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0006-8993(01)02175-8</idno>
<idno type="url">https://api-v5.istex.fr/document/AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000730</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000730</idno>
<idno type="wicri:Area/Istex/Curation">000730</idno>
<idno type="wicri:Area/Istex/Checkpoint">001094</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001094</idno>
<idno type="wicri:doubleKey">0006-8993:2001:Sinclair C:adenosine:permeation:of</idno>
<idno type="wicri:Area/Main/Merge">003747</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11292455</idno>
<idno type="wicri:Area/PubMed/Corpus">001574</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001574</idno>
<idno type="wicri:Area/PubMed/Curation">001574</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001574</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001574</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001574</idno>
<idno type="wicri:Area/Ncbi/Merge">000154</idno>
<idno type="wicri:Area/Ncbi/Curation">000154</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000154</idno>
<idno type="wicri:doubleKey">0006-8993:2001:Sinclair C:adenosine:permeation:of</idno>
<idno type="wicri:Area/Main/Merge">003600</idno>
<idno type="wicri:Area/Main/Curation">003265</idno>
<idno type="wicri:Area/Main/Exploration">003265</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole</title>
<author>
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Avenue, Winnipeg</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName>
<region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Avenue, Winnipeg</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Canada</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Brain Research</title>
<title level="j" type="abbrev">BRES</title>
<idno type="ISSN">0006-8993</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">898</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="122">122</biblScope>
<biblScope unit="page" to="125">125</biblScope>
</imprint>
<idno type="ISSN">0006-8993</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0006-8993</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine (antagonists & inhibitors)</term>
<term>Adenosine (metabolism)</term>
<term>Adenosine transport</term>
<term>Animals</term>
<term>Blood-Brain Barrier (physiology)</term>
<term>Capillary Permeability (drug effects)</term>
<term>Carrier Proteins (antagonists & inhibitors)</term>
<term>Cattle</term>
<term>Cells, Cultured</term>
<term>Cellular and molecular biology</term>
<term>Dipyridamole</term>
<term>Dipyridamole (pharmacology)</term>
<term>Dynamic in vitro blood–brain barrier</term>
<term>Models, Biological</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Adenosine</term>
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adenosine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Capillary Permeability</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Dipyridamole</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Blood-Brain Barrier</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cattle</term>
<term>Cells, Cultured</term>
<term>Models, Biological</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Adenosine is an inhibitory neuromodulator in the central nervous system and has been reported to have neuroprotective properties. Using a dynamic in vitro blood–brain barrier, we investigated the hypothesis that inhibition of adenosine transporters on the lumenal side of the blood–brain barrier may decrease the loss of adenosine from the brain. Our results indicate that lumenal administration of dipyridamole, a nucleoside transport inhibitor, can inhibit adenosine permeation from the extracapillary space into the lumen.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>États-Unis</li>
</country>
<region>
<li>Manitoba</li>
<li>Ohio</li>
</region>
<settlement>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
</region>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
</country>
<country name="États-Unis">
<region name="Ohio">
<name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</region>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
<name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003265 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003265 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611
   |texte=   Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022